Literature DB >> 7036087

[Outcome of the adult acute respiratory distress syndrome. Predictive value of a severity index calculated from arterial oxygenation (author's transl)].

F Jardin, J F Prost, M Bazin, P Desfond, Y Ozier, A Margairaz.   

Abstract

A retrospective study was carried out a group of 50 adult patients who had presented with acute respiratory distress syndrome and had all been treated by mechanically controlled ventilation with positive end-expiratory pressure (PEEP). The predictive value of the so-called "severity index" was tested. This index, which is used from the second day of treatment onward to predict with strong probability whether the lung lesions will subside or develop, is obtained from the PaO2 after corrections taking into account the FiO2 and the PEEP level. The study also supplied information on the outcome of lung lesions which may result in one of four possible courses of about equal frequency: the patient may either die or be cured rapidly after less than a week of assisted ventilation, or he may die at a later date or be cured slowly after more than a week of assisted ventilation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7036087

Source DB:  PubMed          Journal:  Nouv Presse Med        ISSN: 0301-1518


  3 in total

1.  Right ventricular ejection fraction measurement in moderate acute respiratory failure (ARF). Effects of PEEP.

Authors:  A Brienza; M Dambrosio; F Bruno; V Lagioia; M Marucci; G Belpiede; R Giuliani
Journal:  Intensive Care Med       Date:  1988       Impact factor: 17.440

2.  Miliary tuberculosis and adult respiratory distress syndrome.

Authors:  A R Piqueras; L Marruecos; A Artigas; C Rodriguez
Journal:  Intensive Care Med       Date:  1987       Impact factor: 17.440

3.  P/FP ratio: incorporation of PEEP into the PaO2/FiO2 ratio for prognostication and classification of acute respiratory distress syndrome.

Authors:  Sunitha Palanidurai; Jason Phua; Yiong Huak Chan; Amartya Mukhopadhyay
Journal:  Ann Intensive Care       Date:  2021-08-09       Impact factor: 6.925

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.